Multifunction bismuth gadolinium oxide nanoparticles as radiosensitizer in radiation therapy and imaging
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Multifunction bismuth-based nanoparticles with the ability to display diagnostic and therapeutic functions have drawn extensive attention as theranostic agents in radiation therapy and imaging due to their high atomic number, low toxicity, and low cost. Herein, we tried to introduce multifunction bismuth gadolinium oxide nanoparticles (BiGdO 3 ) as a new theranostic agent for radiation therapy, computed tomography (CT) and magnetic resonance imaging (MRI). After synthesis of BiGdO 3 nanoparticles and surface modifications of them with PEG, biocompatibility of the nanoparticles was evaluated by a CCK-8 assay. We investigated dose amplification properties of the nanoparticles using gel dosimetry and in vitro and in vivo assays. According to clonogenic assay radiation, a sensitizer enhancement ratio (SER) of 1.75 and 1.66 (100 µ g ml −1 -nanoparticles), for MCF-7 and 4T1 cell lines at low energy x-ray was achieved, respectively. Radiation dose enhancement effect of the nanoparticles was proven for high concentrations (500 µ g ml −1 ) by gel dosimetry. For further investigation, in vivo cancer radiotherapy was carried out using female BALB/c mice with 4T1 breast tumors. In vivo results emphasized the radiosensitizing effect of BiGdO 3 -PEG nanoparticles. Both bismuth and gadolinium provide CT contrast, while gadolinium can be employed for MRI T1 contrast, so we evaluated contrast enhancement of BiGdO 3 -PEG nanoparticles as a dual-modal imaging agent in MR and CT imaging. Collectively, our experimental results clearly display properties of BiGdO 3 -PEG nanoparticles as multimodal imaging and radiosensitizing agents. The results show that the nanoparticles deserve further study as a new theranostic agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Cited by
Shahbazi, M.-A., Faghfouri, L., Ferreira, M. P. A., Figueiredo, P., Maleki, H., Sefat, F., Hirvonen, J., & Santos, H. A. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00283a · Cited by 523
Application of Radiosensitizers in Cancer Radiotherapy
Gong, L., Zhang, Y., Liu, C., Zhang, M., & Han, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s290438 · Cited by 479
Preparation of alginate coated Pt nanoparticle for radiosensitization of breast cancer tumor
Rashidzadeh, H., Seidi, F., Ghaffarlou, M., Salehiabar, M., Charmi, J., Yaray, K., Nosrati, H., & Ertas, Y. N. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123273 · Cited by 43
Liu, J., Zhao, L., Sun, Y., Fu, Q., & Xiao, W. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102186 · Cited by 9
“…biomaterials-based radiosensitizers, typically based on metals or other inorganic materials such as gold [149 – 151], platinum [152 – 156], oxides [157,158] and sulfides [103, 159], exert effects via physical ( e.g ., enhanced radiation deposition), and chemical ( e.g. , ROS generation) mechanisms.”
Self-citationAlbers, J., Markus, A., Svetlove, A., Kraupner, A., Briel, A., Alves, F., & Dullin, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-02560-4 · Cited by 3
Metadata
- Authors
- Rajaee, A., Wang, S., Zhao, L., Wang, D., Liu, Y., Wang, J., & Ying, K.
- Venue
- Physics in Medicine & Biology
- Publisher
- IOP Publishing
- Published
- 2019-10-01
- Volume
- 64
- Issue
- 19
- Pages
- 195007
- ISSN
- 0031-9155 (ISSN-L)
- 1361-6560
- OpenAlex
- W2946145162
- Cited by
- 53
- References
- 1
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multifunction bismuth gadolinium oxide nanoparticles as radiosensitizer in radiation therapy and imaging. https://app.cochat.ai/papers/10.1088/1361-6560/ab2154
- The paper
- Rajaee, A., Wang, S., Zhao, L., Wang, D., Liu, Y., Wang, J., & Ying, K. (2019). Multifunction bismuth gadolinium oxide nanoparticles as radiosensitizer in radiation therapy and imaging. Physics in Medicine & Biology. https://doi.org/10.1088/1361-6560/ab2154
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.